Susquehanna International Group, LLP Chembio Diagnostics, Inc. Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.2 - $0.33 $11,373 - $18,766	56,869 New	56,869 $12,000
Q2 2022 Aug 15, 2022	SELL	$0.45 - $0.8 $8,381 - $14,900	-18,626 Reduced 21.38%	68,497 $45,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $58,114 - $108,303	-88,052 Reduced 50.27%	87,123 $71,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $55,375 - $129,547	50,803 Added 40.85%	175,175 $200,000
Q3 2021 Nov 15, 2021	BUY	$2.06 - $5.34 $85,685 - $222,117	41,595 Added 50.25%	124,372 $311,000
Q2 2021 Aug 11, 2021	SELL	$2.88 - $5.64 $86,929 - $170,237	-30,184 Reduced 26.72%	82,777 $246,000
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $351,781 - $824,616	-103,465 Reduced 47.81%	112,961 $396,000
Q4 2020 Feb 16, 2021	BUY	$4.11 - $7.51 $534,998 - $977,576	130,170 Added 150.91%	216,426 $1.03 Million
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $174,141 - $314,835	53,092 Added 160.09%	86,256 $419,000
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $105,461 - $515,368	33,164 New	33,164 $108,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.